ATOS · Atossa Therapeutics, Inc.

Summary

Atossa Therapeutics, Inc. filed an 8-K on February 20, 2026, reporting entry into an At the Market Offering Agreement and termination of a prior agreement with Jefferies LLC. The filing includes exhibits detailing these agreements.

Key takeaways

• Entered into At the Market Offering Agreement on February 20, 2026
• Terminated agreement with Jefferies LLC via written notice on February 19, 2026
• Exhibit 1.1: At the Market Offering Agreement dated February 20, 2026 with Rodm